These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6837902)

  • 1. Labetalol in tetanus. The treatment of sympathetic nervous system overactivity.
    Wesley AG; Hariparsad D; Pather M; Rocke DA
    Anaesthesia; 1983 Mar; 38(3):243-9. PubMed ID: 6837902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine in tetanus--the management of sympathetic nervous system overactivity.
    Rocke DA; Wesley AG; Pather M; Calver AD; Hariparsad D
    S Afr Med J; 1986 Nov; 70(11):666-8. PubMed ID: 3787380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
    Hanna W; Grell GA
    South Med J; 1980 May; 73(5):653-4. PubMed ID: 6103586
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
    Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
    Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalol.
    Domenighetti GM; Savary G; Stricker H
    Br Med J (Clin Res Ed); 1984 May; 288(6429):1483-4. PubMed ID: 6426611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
    Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
    Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
    Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory responses to thiopentone and tracheal intubation in patients with coronary artery disease. Effects of pretreatment with labetalol.
    Fischler M; Dubois C; Brodaty D; Schlumberger S; Melchior JC; Guilmet D; Vourc'h G
    Br J Anaesth; 1985 May; 57(5):493-6. PubMed ID: 3888239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
    Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
    J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
    Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
    Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disturbances in severe tetanus due to overactivity of the sympathetic nervous system.
    Corbett JL; Kerr JH; Prys-Roberts C; Smith AC; Spalding JM
    Anaesthesia; 1969 Apr; 24(2):198-212. PubMed ID: 5774711
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions.
    Puchstein C; van Aken H; Hidding J; Anger C; Lawin P
    Acta Neurochir (Wien); 1983; 67(3-4):283-90. PubMed ID: 6846084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.